ADB-INACA
Summary
ADB-INACA is an indazole-3-carboxamide frequently detected as a precursor or minor component alongside potent synthetic cannabinoids in seized products; real-world harms often reflect co-formulation with more active compounds rather than pure ADB-INACA effects. As a suspected precursor to compounds like ADB-BUTINACA, overall potency is expected to be low, though pharmacological data remain limited. Treat unknown powders and sprayed materials as if they contain nanomolar CB1 agonists; never eyeball doses, use a milligram scale or volumetric solutions, start at sub-milligram smoked or low-milligram oral doses, and wait through the full peak before redosing.
Dose Information
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset |
|---|---|---|---|---|
| Oral | 15-45 min | 15-30 min | 30-90 min | 1-2 hrs |
| Smoked | 1 min | 2-5 min | 15-45 min | 30-60 min |
Tolerance
Tolerance Decay
Rapid tolerance build with repeated/daily use is commonly reported for SCRA class; decay appears slower than build and incomplete for weeks. Data quality is low and largely anecdotal across varying compounds/products.
Cross-Tolerances
Effects
- Pain relief
- Physical euphoria
- Dry mouth
- Increased heart rate
- Nausea
- Tachycardia
- Tachycardia and palpitations
- Sedation
- Spontaneous bodily sensations
- Vasodilation
- Euphoria
- Thought connectivity
- Anxiety
- Paranoia
- Motor control loss
- Dizziness
- Confusion
- Short-term memory suppression
- Psychosis
- Time distortion
- Appetite enhancement
- Color enhancement
- Perception of bodily lightness
- Increased Music Appreciation
- Bodily control enhancement
- Dehydration
- Visual distortions
- Appetite intensification
- Changes in felt gravity
- Closed-eye imagery